8-K
Current Report
ELITE PHARMACEUTICALS INC /NV/ Filed Acc 0000930413-05-006459
New debt or obligation
- Item 2.03 Creation of a direct financial obligation
From the SEC's structured data for this filing
Loading c39004_8k.txt…